126 related articles for article (PubMed ID: 8395792)
1. The sign of Leser-Trélat in association with Sézary syndrome: simultaneous disappearance of seborrheic keratoses and malignant T-cell clone during combined therapy with photopheresis and interferon alfa.
Cohen JH; Lessin SR; Vowels BR; Benoit B; Witmer WK; Rook AH
Arch Dermatol; 1993 Sep; 129(9):1213-5. PubMed ID: 8395792
[No Abstract] [Full Text] [Related]
2. [Sézary syndrome and Leser-Trélat sign: a chance association?].
Bursztejn AC; Doumat-Batch F; Granel-Brocard F; Perrin A; Cuny JF; Barbaud A; Schmutz JL
Ann Dermatol Venereol; 2008 Apr; 135(4):287-90. PubMed ID: 18420075
[TBL] [Abstract][Full Text] [Related]
3. Combined therapy for Sézary syndrome with extracorporeal photochemotherapy and low-dose interferon alfa therapy. Clinical, molecular, and immunologic observations.
Rook AH; Prystowsky MB; Cassin M; Boufal M; Lessin SR
Arch Dermatol; 1991 Oct; 127(10):1535-40. PubMed ID: 1929461
[TBL] [Abstract][Full Text] [Related]
4. Monitoring the decrease of circulating malignant T cells in cutaneous T-cell lymphoma during photopheresis and interferon therapy.
Ferenczi K; Yawalkar N; Jones D; Kupper TS
Arch Dermatol; 2003 Jul; 139(7):909-13. PubMed ID: 12873887
[TBL] [Abstract][Full Text] [Related]
5. Follow-up of the T-cell clonality in Sezary patients treated by extracorporeal photopheresis using a new assay: the immunoscope technique.
Ingen-Housz-Oro S; Bussel A; Flageul B; Dubertret L; Michel L; Gachelin G; Kourilsky P; Bachelez H; Musette P
Transfus Apher Sci; 2003 Feb; 28(1):35-42. PubMed ID: 12620267
[TBL] [Abstract][Full Text] [Related]
6. Sustained remission of Sézary syndrome.
Bouwhuis SA; McEvoy MT; Davis MD
Eur J Dermatol; 2002; 12(3):287-90. PubMed ID: 11978575
[TBL] [Abstract][Full Text] [Related]
7. [Leser-Trélat sign associated with Sézary syndrome and transitional cell carcinoma of the bladder].
Martínez-Morán C; Sanz-Muñoz C; Miranda-Romero A
Actas Dermosifiliogr; 2007 Apr; 98(3):214-5. PubMed ID: 17504710
[No Abstract] [Full Text] [Related]
8. The sign of Leser-Trelat associated with esophageal carcinoma.
Chiba T; Shitomi T; Nakano O; Shimotono H; Yamada H; Fujimaki E; Orii S; Sato K; Sato S
Am J Gastroenterol; 1996 Apr; 91(4):802-4. PubMed ID: 8677957
[TBL] [Abstract][Full Text] [Related]
9. Combination therapy with extracorporeal photopheresis, interferon-alpha, PUVA and topical corticosteroids in the management of Sézary syndrome.
Booken N; Weiss C; Utikal J; Felcht M; Goerdt S; Klemke CD
J Dtsch Dermatol Ges; 2010 Jun; 8(6):428-38. PubMed ID: 20180887
[TBL] [Abstract][Full Text] [Related]
10. Leser-Trélat sign associated with Sézary syndrome.
Horiuchi Y; Katsuoka K; Tsukamoto K; Takezaki S
Cutis; 1985 Nov; 36(5):409-10. PubMed ID: 2933229
[TBL] [Abstract][Full Text] [Related]
11. A prospective study on the evolution of the T-cell repertoire in patients with Sézary syndrome treated by extracorporeal photopheresis.
Ingen-Housz-Oro S; Bussel A; Flageul B; Michel L; Dubertret L; Kourilsky P; Gachelin G; Bachelez H; Musette P
Blood; 2002 Sep; 100(6):2168-74. PubMed ID: 12200382
[TBL] [Abstract][Full Text] [Related]
12. Post-renal transplantation Leser-Trélat sign associated with carcinoma of the gallbladder: a rare association.
Kocyigit P; Akay BN; Arica E; Anadolu RY; Erdem C
Scand J Gastroenterol; 2007 Jun; 42(6):779-81. PubMed ID: 17506003
[TBL] [Abstract][Full Text] [Related]
13. Sign of Leser-Trélat.
Schwartz RA
J Am Acad Dermatol; 1996 Jul; 35(1):88-95. PubMed ID: 8682971
[TBL] [Abstract][Full Text] [Related]
14. Extracorporeal photopheresis and recombinant interferon alfa 2b in Sezary syndrome. Use of dual marker labeling to monitor therapeutic response.
Vonderheid EC; Bigler RD; Greenberg AS; Neukum SJ; Micaily B
Am J Clin Oncol; 1994 Jun; 17(3):255-63. PubMed ID: 8192114
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy-induced inflammatory seborrheic keratoses in a man with acute myeloid leukemia: a variant of Leser-Trélat sign?
Lilly E; Granter SR; Haynes HA; Ibrahimi OA
Cutis; 2012 Nov; 90(5):235-6. PubMed ID: 23270192
[TBL] [Abstract][Full Text] [Related]
16. Leser-Trélat sign associated with Sézary syndrome.
Ikari Y; Ohkura M; Morita M; Seki K; Kubota Y; Mizoguchi M
J Dermatol; 1995 Jan; 22(1):62-7. PubMed ID: 7897028
[TBL] [Abstract][Full Text] [Related]
17. Extracorporeal photopheresis in Sézary syndrome.
Russell-Jones R; Fraser-Andrews E; Spittle M; Whittaker S
Lancet; 1997 Sep; 350(9081):886. PubMed ID: 9310623
[No Abstract] [Full Text] [Related]
18. Inflammation of seborrheic keratoses caused by cytarabine: a pseudo sign of Leser-Trelat.
Patton T; Zirwas M; Nieland-Fisher N; Jukic D
J Drugs Dermatol; 2004; 3(5):565-6. PubMed ID: 15552612
[TBL] [Abstract][Full Text] [Related]
19. Sign of Leser-Trélat associated with adenocarcinoma of the rectum.
Ginarte M; Sánchez-Aguilar D; Toribio J
Eur J Dermatol; 2001; 11(3):251-3. PubMed ID: 11358736
[TBL] [Abstract][Full Text] [Related]
20. Leser-Trélat syndrome in patients affected by six multiple metachronous primitive cancers.
Ponti G; Luppi G; Losi L; Giannetti A; Seidenari S
J Hematol Oncol; 2010 Jan; 3():2. PubMed ID: 20064244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
